OAuth redirection is being repurposed as a phishing delivery path. Trusted authentication flows are weaponized to move users from legitimate sign‑in pages to attacker‑controlled infrastructure.
A quiz funnel software is the platform that lets you design a multi-step quiz, adapt questions based on answers, calculate an ...
ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) ...
Announcing the Fabricate Data Agent, synthetic data generation via agentic AI. Plus, Structural's Custom Categorical is now AI-assisted, and Model-based Custom Entities are coming to Textual!
ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countriesDublin-based subsidiary to support ImmunityBio’s distribution and ...
ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...
On 25–26 February 2026, African ministers responsible for trade will gather in Maputo, Republic of Mozambique, under the African Union (AU) framework. This meeting comes just weeks before the ...
The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC), New Delhi, has invited online applications for starting new Post Graduate medical courses in ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) ...
Insplorion AB (publ) ("Insplorion" or the "Company") announces today that the Company has entered into a business transfer agreement (the "Business Transfer Agreement") with Mann Teknik AB ("MannTek") ...
News-Medical.Net on MSN
Researchers identify TRIM13 protein as key driver of immune suppression in sepsis
Dendritic cells (DCs) are increasingly recognized as important contributors to sepsis-associated immune dysfunction. As professional antigen-presenting cells, they bridge innate sensing and durable ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced that the Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results